Doing Research on People

Nowhere is the potential for conflicting obligations more worrisome than in situations where doctors simultaneously deliver medical care to patients and use them as research subjects. The idea of experimenting on patients conjures up two quite different pictures. The first depicts persons who are sick and suffering—perhaps even dying—being subjected to the manipulations of clinical investigators who use patients in their efforts to contribute to scientific knowledge, as well as

Written byRuth Macklin
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Nowhere is the potential for conflicting obligations more worrisome than in situations where doctors simultaneously deliver medical care to patients and use them as research subjects.

The idea of experimenting on patients conjures up two quite different pictures. The first depicts persons who are sick and suffering—perhaps even dying—being subjected to the manipulations of clinical investigators who use patients in their efforts to contribute to scientific knowledge, as well as to promote their own careers. The second picture portrays untold numbers of present and future patients receiving the benefits of miraculous cures resulting from painstaking research in hospitals and laboratories. Neither of these pictures is an accurate rendering of the actual conduct of research involving human subjects, yet both contain partial truths.

The actual contribution to medical knowledge gained by most clinical trials is only a pale rendering of the image of miraculous breakthroughs in scientific understanding and control of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies